Skip to content
Disclosery

MARSHALL WACE, LLP: EXLS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on EXLS, newest first. How the timeline and the estimate are built.

MARSHALL WACE, LLP held 1,029,164 EXLS shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,029,164 shares
    Change vs previous 13F +608,207 shares

    0.02% of the 13F portfolio, value $26,614,180.

    13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 420,957 shares
    Change vs previous 13F +380,002 shares

    0.01% of the 13F portfolio, value $12,818,140.

    13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 40,955 shares
    Change vs previous 13F -456,291 shares

    <0.01% of the 13F portfolio, value $1,738,130.

    13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 497,246 shares
    Change vs previous 13F +458,337 shares

    0.02% of the 13F portfolio, value $21,893,741.

    13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 38,909 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,703,825.

    13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).